XML 37 R27.htm IDEA: XBRL DOCUMENT v3.23.3
Summary of Significant Accounting Policies (Details)
$ in Thousands
3 Months Ended 9 Months Ended 12 Months Ended
Jun. 21, 2023
shares
Sep. 30, 2023
USD ($)
Sep. 30, 2022
USD ($)
Sep. 30, 2023
USD ($)
Sep. 30, 2022
USD ($)
Dec. 31, 2022
USD ($)
Research and development incentive income and receivable            
Research and development expenses reimbursed (as a percent)       43.50%   43.50%
Research and development incentive receivable   $ 753   $ 753   $ 2,099
Research and development incentive income and receivable            
Balance at the beginning of the period       2,099 $ 1,189 1,189
Australian research and development incentive income   554 $ 652 1,124 $ 1,276 2,051
Cash received for eligible expenses       (2,333)   (1,064)
Foreign currency translation       (137)   (77)
Balance at the end of the period   753   753   2,099
Other Assets            
Deposits   $ 913   $ 913   1,108
Incremental borrowing rate   8.00%   8.00%    
Reverse stock split, conversion ratio 0.1          
Series X Preferred Stock            
Other Assets            
Conversion ratio | shares 100          
License and Service            
Other Assets            
Deposits   $ 913   $ 913   $ 1,108